Data Sheet
Quantify biodistribution, enhance in vivo decisions
Non-invasive preclinical SPECT imaging of test agent biodistribution, kinetics and targeting in discovery and safety applications has key advantages over pre-existing methods including:
- full 3-dimensionality with tissue and sub-tissue localization
- fine kinetics, targeting, binding and clearance pathways can be examined
- clinical translatability
- isotope multiplexing to cost effectively address multiple questions simultaneously
- SPECT isotope utility
- longer half-lives improve study design and reduce quantity of tracer and animals
- widely available, facilitating research goals
